Loading organizations...
UTC 2019 BIOVENTUREFUND is a specialized venture capital fund investing in early and growth-stage biotechnology and healthcare companies. The firm employs a sector-specific strategy, targeting innovative technologies across bio, healthcare, beauty, semiconductors, and artificial intelligence. It provides capital and practical guidance, emphasizing high-growth potential and scalable business models.
Established in 2019, the fund operates under UTC Investment Co., Ltd., a South Korean venture capital firm founded in 1988. UTC Investment launched this dedicated fund to capitalize on opportunities in bio-related industries and facilitate the global expansion of domestic startups, particularly into markets like Japan, leveraging its extensive experience.
The fund supports startups with innovative technologies and strong management teams, aiming to cultivate future market leaders. Its vision is to generate long-term value for investors and portfolio companies by supporting their development and international growth. UTC 2019 BIOVENTUREFUND seeks to be a pivotal partner in advancing groundbreaking solutions across critical technology industries.
UTC 2019 BIOVENTUREFUND has 1 tracked investment across 1 company. The latest tracked deal is $15.4M Series B in PDC*line Pharma in January 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 22, 2020 | PDC*line Pharma | $15.4M Series B | — | Financière Spin OFF Luxembourgeoise, Sangwoo LEE, Noshaq, Sambrinvest, Sfpi Fpim, Shinhan Cognitive Start UP Fund |
